Molecular Templates, Inc. Quarterly Debt-to-equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Molecular Templates, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q2 2024.
  • Molecular Templates, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 455 %.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 455 +2.09K Jun 30, 2024
Q1 2024 1.63K -1.58K -49.2% Mar 31, 2024
Q4 2023 45.4K +44.7K +6106% Dec 31, 2023
Q3 2023 -1.45K -1.78K -541% Sep 30, 2023
Q2 2023 -1.63K -1.87K -785% Jun 30, 2023
Q1 2023 3.21K +3.02K +1596% Mar 31, 2023
Q4 2022 732 +568 +346% Dec 31, 2022
Q3 2022 329 +176 +115% Sep 30, 2022
Q2 2022 238 +108 +82.4% Jun 30, 2022
Q1 2022 189 +61.1 +47.6% Mar 31, 2022
Q4 2021 164 +47.9 +41.3% Dec 31, 2021
Q3 2021 153 +55.6 +56.9% Sep 30, 2021
Q2 2021 131 +37.6 +40.4% Jun 30, 2021
Q1 2021 128 +58.4 +83.5% Mar 31, 2021
Q4 2020 116 +58.2 +101% Dec 31, 2020
Q3 2020 97.7 +48.9 +100% Sep 30, 2020
Q2 2020 93 +49.3 +113% Jun 30, 2020
Q1 2020 70 +29.8 +74.2% Mar 31, 2020
Q4 2019 57.9 +23.1 +66.2% Dec 31, 2019
Q3 2019 48.9 +19.7 +67.4% Sep 30, 2019
Q2 2019 43.7 +23.1 +113% Jun 30, 2019
Q1 2019 40.2 +21.2 +112% Mar 31, 2019
Q4 2018 34.8 +16.4 +89.2% Dec 31, 2018
Q3 2018 29.2 -21 -41.8% Sep 30, 2018
Q2 2018 20.5 -191 -90.3% Jun 30, 2018
Q1 2018 19 -121 -86.5% Mar 31, 2018
Q4 2017 18.4 -69.4 -79% Dec 31, 2017
Q3 2017 50.1 -11.2 -18.2% Sep 30, 2017
Q2 2017 211 -3.34K -94% Jun 30, 2017
Q1 2017 140 +565 Mar 31, 2017
Q4 2016 87.8 +390 Dec 31, 2016
Q3 2016 61.3 +452 Sep 30, 2016
Q2 2016 3.55K +3.98K Jun 30, 2016
Q1 2016 -425 +16.1 +3.66% Mar 31, 2016
Q4 2015 -302 +114 +27.5% Dec 31, 2015
Q3 2015 -391 +62.4 +13.8% Sep 30, 2015
Q2 2015 -437 +54.3 +11.1% Jun 30, 2015
Q1 2015 -441 +84.2 +16% Mar 31, 2015
Q4 2014 -417 +164 +28.3% Dec 31, 2014
Q3 2014 -454 +168 +27.1% Sep 30, 2014
Q2 2014 -491 -15.5 -3.26% Jun 30, 2014
Q1 2014 -525 -138 -35.7% Mar 31, 2014
Q4 2013 -581 -293 -102% Dec 31, 2013
Q3 2013 -622 -353 -131% Sep 30, 2013
Q2 2013 -475 -179 -60.5% Jun 30, 2013
Q1 2013 -387 +52.1 +11.9% Mar 31, 2013
Q4 2012 -288 Dec 31, 2012
Q3 2012 -269 Sep 30, 2012
Q2 2012 -296 Jun 30, 2012
Q1 2012 -439 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.